Duality Biotherapeutics, Inc. (HKG:9606)
Hong Kong · Delayed Price · Currency is HKD 171.30
+2.70 (1.60%)
Oct 21, 2026, 1:43 PM HKT
Duality Biotherapeutics Market Cap
Duality Biotherapeutics has a market cap or net worth of 15.51 billion as of October 20, 2026. It is the 6,647th most valuable company in the world and the 334th biggest in Hong Kong. Its market cap has decreased by 48.18% in one year.
Market Cap
15.51B
Enterprise Value
12.44B
Revenue
972.22M
Global Rank
Country Rank
#334 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since April 15, 2025, Duality Biotherapeutics's market cap has decreased from 17.51B to 15.51B, a decrease of -11.44%. That is a compound annual growth rate of -7.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 15.51B | -41.83% |
| Dec 31, 2025 | 26.66B | 52.24% |
| Apr 15, 2025 | 17.51B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shanghai Henlius Biotech | 28.00B |
| InnoCare Pharma | 25.93B |
| Keymed Biosciences | 24.14B |
| InSilico Medicine Cayman TopCo | 22.52B |
| Zai Lab | 20.43B |
| Metis TechBio | 14.10B |
| Everest Medicines | 11.38B |
| Ascentage Pharma Group International | 10.94B |